Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center

Cleveland, Ohio 44146

5 studies enrolling now · 24 studies all time

What they study most

Critically Ill, Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Lung, Cystic Fibrosis Pulmonary Exacerbation, Cystic Fibrosis in Children, Dexmedetomidine, Exocrine Pancreatic Insufficiency (EPI), Mechanical Ventilation Complication, Persistent Infection, Pregnancy Related, Pseudomonas Aeruginosa

Studies at this site

• Phase 2 Study to Assess the Safety and Efficacy of ANG003 — Recruiting now
• Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study — Recruiting now
• 4D-710 in Adult Patients With Cystic Fibrosis — Recruiting now
• A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators — Recruiting now
• Rethinking Early Airway Clearence Therapies — Starting soon
• A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection — Completed
• Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age — Running, not enrolling
• A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis — Completed
• The PROMISE Pediatric Study 6 to 11 Years Old — Completed
• Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF) — Completed
• Prospective Study of Pregnancy in Women With Cystic Fibrosis — Running, not enrolling
• CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older — Completed
• Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy — Completed
• Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study — Completed
• Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study — Completed
• A Study to Evaluate the Safety and Efficacy of Long-term Treatment With TEZ/IVA in CF Participants With an F508del CFTR Mutation — Completed
• Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis — Completed
• DOSE Trial of Opioid Sparing Effect — Stopped early
• Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
• A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F) — Completed